← Open Payments lookup

KEVIN MYIRSKI: Open Payments

NPI 1982190112 · FORT HOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$808 in 31 payments from 12 companies in 2025. Trend: 2023 $82 · 2024 $1,496 · 2025 $808

Food & beverage: $808
CompanyPaymentsAmount
ABBVIE INC.14$224
LivaNova USA, Inc.1$117
Janssen Pharmaceuticals, Inc3$103
Teva Pharmaceuticals USA, Inc.3$102
E.R. Squibb & Sons, L.L.C.2$55
Alkermes, Inc.2$43
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$34
Axsome Therapeutics, Inc.1$33
Corium, LLC1$32
Neurocrine BioSciences, Inc.1$25

Products named: VRAYLAR, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, SPRAVATO, AUSTEDO XR, COBENFY, LYBALVI, REXULTI, CAPLYTA.

Industry payments across TX — which companies pay providers there.